Close Menu

NEW YORK – Biodesix said on Tuesday that it has closed on a new $30 million term loan, which will mature on Mar. 1, 2026.

The Boulder, Colorado-based firm used the proceeds to repay outstanding borrowings of $25.9 million under its existing loan with Innovatus Life Sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.